4 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
5 Aug 20
Regeneron Reports Second Quarter 2020 Financial and Operating Results
7:15am
, Type 2 inflammatory diseases, pain, and rare diseases."
"Regeneron’s business continues to be resilient during these times, delivering double digit
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
22 Dec 06
Entry into a Material Definitive Agreement
12:00am
, & FINISH HARDWARE
OVERHEAD DOORS, SHUTTERS, & GRILLS
WINDOWS, GLASS, & GLAZING
GYPSUM DRYWALL
TILE
ACOUSTICAL CEILINGS
INTERIOR STONEWORK
RESILIENT FLOORING
- Prev
- 1
- Next